Literature DB >> 31076367

Duodenal switch in revisional bariatric surgery: conclusions from an expert consensus panel.

Alexa E Merz1, Robin B Blackstone2, Michel Gagner3, Antonio J Torres4, Jacques Himpens5, Kelvin D Higa6, Raul J Rosenthal7, Aaron Lloyd8, Eric J DeMaria9.   

Abstract

BACKGROUND: Duodenal switch (BPD/DS) is gaining popularity as a secondary procedure for inadequate weight loss after an initial operation.
OBJECTIVES: We aimed to generate expert consensus points on the appropriate use of BPD/DS in the revisional bariatric surgical setting.
SETTING: Data were gathered at an international conference with attendees from a variety of different institutions and settings.
METHODS: Sixteen lines of questioning regarding revisional BPD/DS were presented to an expert panel of 29 bariatric surgeons. Current available literature was reviewed extensively for each topic and proposed to the panel before polling. Responses were collected and topics defined as achieving consensus (≥70% agreement) or no consensus (<70% agreement).
RESULTS: Consensus was present in 10 of 16 lines of questioning, with several key points most prominent.
CONCLUSIONS: As a second-stage procedure, BPD/DS is most appropriate after sleeve gastrectomy (SG) for the treatment of super morbid obesity (96.7% agree) or as a subsequent operation for a reliable patient with insufficient weight loss after SG (88.5%). In a patient with weight regain and reflux and/or enlarged fundus after SG, Roux-en-Y gastric bypass is preferable and BPD/DS should be avoided (90%). BPD/DS should not be used prophylactically in patients with a history of jejunoileal bypass who are otherwise doing well (80.8%). Applicability of BPD/DS is limited by technical difficulty; 86.2% of experts would routinely recommend or consider the procedure if it were more technically feasible after failed bypass. No consensus was found on approaches to revision of BPD/DS for protein malnutrition.
Copyright © 2019 American Society for Bariatric Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Duodenal switch; Expert consensus; Obesity; Revisional bariatric surgery

Mesh:

Year:  2019        PMID: 31076367     DOI: 10.1016/j.soard.2019.03.009

Source DB:  PubMed          Journal:  Surg Obes Relat Dis        ISSN: 1550-7289            Impact factor:   4.734


  6 in total

1.  Options in Bariatric Surgery: Modeled Decision Analysis Supports One-Anastomosis Gastric Bypass as the Treatment of Choice when Type 2 Diabetes Is Present.

Authors:  Conor Brosnan; Jarlath C Bolger; Eamonn M Bolger; Michael E Kelly; Roisin Tully; Mohamed AlAzzawi; William B Robb
Journal:  Obes Surg       Date:  2020-08-21       Impact factor: 4.129

2.  Duodenal Switch Conversion in Non-responders or Weight Recurrence Patients.

Authors:  Romulo Lind; Omar M Ghanem; Muhammad Ghanem; Andre F Teixeira; Muhammad A Jawad
Journal:  Obes Surg       Date:  2022-10-08       Impact factor: 3.479

3.  Safety of Primary Versus Revisional Biliopancreatic Diversion with Duodenal Switch in Patients with Super Obesity Using the MBSAQIP database.

Authors:  Alice Wang; Huaping Wang; Alexander Abdurakhmanov; Vilok Vijayanagar; Kyle J Thompson; Iain H Mckillop; Selwan Barbat; Roc Bauman; Keith S Gersin; Timothy S Kuwada; Abdelrahman Nimeri
Journal:  Obes Surg       Date:  2022-02-08       Impact factor: 3.479

4.  Long-Term Efficacy of Bariatric Surgery for the Treatment of Super-Obesity: Comparison of SG, RYGB, and OAGB.

Authors:  Tien-Chou Soong; Ming-Hsien Lee; Wei-Jei Lee; Owaid M Almalki; Jung-Chien Chen; Chun-Chi Wu; Shu-Chun Chen
Journal:  Obes Surg       Date:  2021-05-16       Impact factor: 4.129

Review 5.  Revisional Surgeries of Laparoscopic Sleeve Gastrectomy.

Authors:  Siyuan Li; Siqi Jiao; Siwei Zhang; Jiangjiao Zhou
Journal:  Diabetes Metab Syndr Obes       Date:  2021-02-10       Impact factor: 3.168

6.  The first survey addressing patients with BMI over 50: a survey of 789 bariatric surgeons.

Authors:  Mohammad Kermansaravi; Panagiotis Lainas; Shahab Shahabi Shahmiri; Wah Yang; Amirhossein Davarpanah Jazi; Ramon Vilallonga; Luciano Antozzi; Chetan Parmar; Radwan Kassir; Sonja Chiappetta; Lorea Zubiaga; Antonio Vitiello; Kamal Mahawar; Miguel Carbajo; Mario Musella; Scott Shikora
Journal:  Surg Endosc       Date:  2022-01-21       Impact factor: 3.453

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.